Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Vir Biotechnology, Inc. (VIR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/03/2023 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
| 08/04/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/03/2023 |
8-K
| Quarterly results |
| 07/20/2023 |
8-K
| Quarterly results |
| 07/05/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Sold 700 shares
@ $25.11, valued at
$17.6k
|
|
| 07/03/2023 |
4
| SATO VICKI L (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Sold 18,000 shares
@ $24.662, valued at
$443.9k
|
|
| 06/30/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Sold 7,010 shares
@ $25.0958, valued at
$175.9k
Sold 89,942 shares
@ $25.1799, valued at
$2.3M
|
|
| 06/30/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/29/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/15/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Sold 36,547 shares
@ $26.8058, valued at
$979.7k
Sold 70,307 shares
@ $27.2307, valued at
$1.9M
Sold 20,967 shares
@ $25.9213, valued at
$543.5k
Sold 36,281 shares
@ $26.2431, valued at
$952.1k
|
|
| 06/08/2023 |
4
| Pang Phillip (Chief Medical Officer) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Sold 5,000 shares
@ $25.9454, valued at
$129.7k
Exercised 5,000 options to buy
@ $1.53, valued at
$7.7k
|
|
| 06/07/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/06/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Sold 34,365 shares
@ $27.3165, valued at
$938.7k
Sold 5,197 shares
@ $27.3231, valued at
$142k
|
|
| 06/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/02/2023 |
4
| Rice Steven J. (Chief Administrative Officer) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Sold 2,500 shares
@ $25.67, valued at
$64.2k
|
|
| 06/02/2023 |
4
| Ramasastry Saira (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Sold 3,500 shares
@ $25.67, valued at
$89.8k
|
|
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/25/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Sold 2,317 shares
@ $25.8385, valued at
$59.9k
Sold 144,402 shares
@ $26.6104, valued at
$3.8M
Sold 23,348 shares
@ $27.0159, valued at
$630.8k
Sold 35,307 shares
@ $25.8911, valued at
$914.1k
Sold 66,754 shares
@ $26.2527, valued at
$1.8M
Sold 2,323 shares
@ $27.1155, valued at
$63k
|
|
| 05/24/2023 |
4
| NELSEN ROBERT (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 6,027 shares
@ $0
Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
| 05/24/2023 |
4
| PEREZ ROBERT J (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 6,027 shares
@ $0
Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
| 05/24/2023 |
4
| Ramasastry Saira (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 6,027 shares
@ $0
Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
| 05/24/2023 |
4
| Napolitano Janet (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 6,027 shares
@ $0
Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
| 05/24/2023 |
4
| MORE ROBERT J (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 6,027 shares
@ $0
Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
| 05/24/2023 |
4
| SATO VICKI L (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 6,027 shares
@ $0
Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
| 05/24/2023 |
4
| SHARP PHILLIP A (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 6,027 shares
@ $0
Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
| 05/24/2023 |
4
| Hatfield Jeffrey S. (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 6,027 shares
@ $0
Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
| 05/24/2023 |
4
| Sigal Charles Elliott (Director) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Granted 6,027 shares
@ $0
Granted 12,054 options to buy
@ $25.74, valued at
$310.3k
|
|
| 05/23/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Sold 91,651 shares
@ $25.3814, valued at
$2.3M
Sold 91,896 shares
@ $25.7237, valued at
$2.4M
|
|
| 05/23/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/19/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/09/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Sold 136 shares
@ $25.1032, valued at
$3.4k
|
|
| 05/08/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/05/2023 |
4
| SVF Endurance (Cayman) Ltd (10% Owner) has filed a Form 4 on Vir Biotechnology, Inc.|
Txns:
| Sold 83,674 shares
@ $25.512, valued at
$2.1M
Sold 114,332 shares
@ $25.5498, valued at
$2.9M
|
|
|
|
|